Expand STRO Menu
STRO MENU

STRO Latest Press Releases

-- February 25, 2026 --

Sutro Biopharma to Participate in Upcoming Investor Conferences Globe Newswire 8:30 AM

-- February 23, 2026 --

Sutro Biopharma Announces Participation at the 16th World ADC London Summit Globe Newswire 8:30 AM

-- February 10, 2026 --

Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering Globe Newswire 7:00 AM

-- January 7, 2026 --

Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 4:05 PM

-- December 17, 2025 --

Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement Globe Newswire 4:05 PM

-- December 16, 2025 --

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- December 3, 2025 --

Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors Globe Newswire 8:00 AM

-- December 1, 2025 --

Sutro Biopharma Announces 1-for-10 Reverse Stock Split Globe Newswire 8:00 AM

-- November 12, 2025 --

Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day Globe Newswire 10:00 AM

-- November 6, 2025 --

Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights Globe Newswire 4:30 PM

-- November 5, 2025 --

Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025 Globe Newswire 4:05 PM

-- November 3, 2025 --

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes